Alfred T. Harding

1.1k total citations · 1 hit paper
14 papers, 522 citations indexed

About

Alfred T. Harding is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Alfred T. Harding has authored 14 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Alfred T. Harding's work include Influenza Virus Research Studies (7 papers), Respiratory viral infections research (5 papers) and interferon and immune responses (3 papers). Alfred T. Harding is often cited by papers focused on Influenza Virus Research Studies (7 papers), Respiratory viral infections research (5 papers) and interferon and immune responses (3 papers). Alfred T. Harding collaborates with scholars based in United States, Netherlands and Sweden. Alfred T. Harding's co-authors include Nicholas S. Heaton, Brook E. Heaton, Rebekah E. Dumm, Matthew T. Sacco, David Sachs, Edward M. Kennedy, Heather M. Froggatt, Jean K. Lim, Marisa Goff and Ryan R. Chaparian and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

Alfred T. Harding

14 papers receiving 509 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection

2022 117 citations Alfred T. Harding, Nicholas S. Heaton Cancers profile →

Peers

Countries citing papers authored by Alfred T. Harding

Since Specialization

Citations

This map shows the geographic impact of Alfred T. Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred T. Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred T. Harding more than expected).

Fields of papers citing papers by Alfred T. Harding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred T. Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred T. Harding. The network helps show where Alfred T. Harding may publish in the future.

Co-authorship network of co-authors of Alfred T. Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred T. Harding. A scholar is included among the top collaborators of Alfred T. Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred T. Harding. Alfred T. Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Human otic progenitor cell models of congenital hearing loss reveal potential pathophysiologic mechanisms of Zika virus and cytomegalovirus infections 2024 ·mBio ·Alfred T. Harding, Karen E. Ocwieja, (unknown), Yichen Zhang, Valerie Leger, N. Jhala, Konstantina M. Stanković, Lee Gehrke	4
2	Abortive infection of bat fibroblasts with SARS-CoV-2 2024 ·Proceedings of the National Academy of Sciences ·(unknown), Michael D. Gallagher, M. Inmaculada Barrasa, Julie Boucau, Alfred T. Harding, Marion Déjosez, (unknown), Margaret E. Bisher, Giovanni de Nola, Abigail K. R. Lytton‐Jean, Lee Gehrke, Thomas P. Zwaka, Rudolf Jaenisch	3
3	Mechanisms of Neuroinvasion and Neuropathogenesis by Pathologic Flaviviruses 2023 ·Viruses ·(unknown), Alfred T. Harding	17
4	The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection breakdown → 2022 ·Cancers ·Alfred T. Harding, Nicholas S. Heaton	117
5	Single-cell genome-wide association reveals that a nonsynonymous variant in ERAP1 confers increased susceptibility to influenza virus 2022 ·Cell Genomics ·(unknown), Liuyang Wang, Xinyu Zhu, Alfred T. Harding, Emily R. Ko, (unknown), E. Washington, Thomas W. Burke, (unknown), Emma Bergstrom, Zoe Gardener, (unknown), Richard G. Brennan, Christopher Chiu, Micah T. McClain, Christopher W. Woods, Simon G. Gregory, Nicholas S. Heaton, Dennis C. Ko	6
6	A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice 2022 ·Journal of Virology ·Ryan R. Chaparian, Alfred T. Harding, Cait E. Hamele, (unknown), Amelia Karlsson, Gregory D. Sempowski, Nicholas S. Heaton, Brook E. Heaton	15
7	GPER1 is required to protect fetal health from maternal inflammation 2021 ·Science ·Alfred T. Harding, Marisa Goff, Heather M. Froggatt, Jean K. Lim, Nicholas S. Heaton	41
8	ETV7 limits antiviral gene expression and control of influenza viruses 2021 ·Science Signaling ·Heather M. Froggatt, Alfred T. Harding, Ryan R. Chaparian, Nicholas S. Heaton	19
9	Influenza viruses that require 10 genomic segments as antiviral therapeutics 2019 ·PLoS Pathogens ·Alfred T. Harding, Griffin D. Haas, Benjamin S. Chambers, Nicholas S. Heaton	2
10	Control of antiviral innate immune response by protein geranylgeranylation 2019 ·Science Advances ·Shigao Yang, Alfred T. Harding, Catherine Sweeney, David Miao, (unknown), Connie J. Zhou, Zhaozhao Jiang, Katherine A. Fitzgerald, Gianna Hammer, Martin O. Bergö, Heather K. Kroh, D. Borden Lacy, Chunxiang Sun, Michael Glogauer, Loretta G. Que, Nicholas S. Heaton, Donghai Wang	53
11	Efforts to Improve the Seasonal Influenza Vaccine 2018 ·Vaccines ·Alfred T. Harding, Nicholas S. Heaton	92
12	A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor 2017 ·Cell Reports ·Brook E. Heaton, Edward M. Kennedy, Rebekah E. Dumm, Alfred T. Harding, Matthew T. Sacco, David Sachs, Nicholas S. Heaton	109
13	Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs 2017 ·mBio ·Alfred T. Harding, Brook E. Heaton, Rebekah E. Dumm, Nicholas S. Heaton	36
14	The revolt of the actors 1973 ·Alfred T. Harding	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact